Atrial Fibrillation Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have paroxysmal atrial fibrillation (an irregular heartbeat that comes and goes), with symptoms, and where the episodes stop on their own or with treatment within 7 days of starting
- People aged between 18 and 70 years old
- People who are willing and able to give informed consent to participate
- People who are able and willing to attend and complete all required appointments and follow-up visits before, during, and after the trial
Who may not be able to join:
- People who have been diagnosed with persistent atrial fibrillation, meaning episodes that last longer than 7 days
- People who have previously had an ablation procedure on the left side of the heart
- People who have previously had heart surgery
- People who have had a heart attack within the last 3 months
- People whose heart's pumping function is significantly reduced (confirm with trial site)
- People who have an implanted pacemaker, implantable defibrillator (ICD), or other metal heart device that could interfere with the type of energy used in the procedure
- People who have an acute illness, active infection throughout the body, or sepsis (a serious infection affecting the whole body)
- People who have a blood clot, tumour, abnormal growth, or structural abnormality inside the heart that would make it unsafe to pass a catheter (a thin tube) through
- People who have severe leaking of the mitral valve in the heart
- People who are pregnant, breastfeeding, or planning to become pregnant during the course of the trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Tom De Potter, MD, Cardiovascular Research Center Aalst
Phone: +34 697539354
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Acute HRV variation (PF-only vs. RF-only arm)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.